by Steven A. Grossman | Nov 11, 2025 | Uncategorized
This week’s questions:Any initial thoughts on CDER Director George Tidmarsh’s response to being accused of abusing his office?Your column on national uniformity and federal preemption (here) was critical of both industry and consumer advocates who are involved in the...
by Steven A. Grossman | Nov 3, 2025 | Uncategorized
This week’s questions:What do you think about this past week’s stories on increased lobbying by pharma (and others) this year? Why was your analysis (here) of the nine vouchers awarded under the National Priority Review Voucher Initiative more positive than most? Q:...
by Steven A. Grossman | Oct 31, 2025 | Short Takes and Updates
To keep our country safe, counterterrorism efforts must be operational and effective 24/7/365. It only takes one terrorist at one specific moment to create a catastrophe.When it comes to food and medical products, FDA is our nation’s Department of Homeland Security....
by Steven A. Grossman | Oct 27, 2025 | Uncategorized
This week’s questions:It appears that no progress has been made to end the federal government shutdown. What happens next? There have been recent headlines that FDA’s FY 26 funding might be appropriated, separate from resolution of the shutdown. Is this true and...
by Steven A. Grossman | Oct 24, 2025 | Short Takes and Updates
Since the founding of our republic, there has been debate about states’ rights vs federal rights. And in times of stress, the discussion gets more heated and gains more traction. Once again, FDA is moving into the center of such debates. Federalism is at the Heart of...
